pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4323 |
Genomic Coordinates | chr19: 42133445 - 42133513 |
Description | Homo sapiens miR-4323 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4323 | ||||||||||||||||||
Sequence | 42| CAGCCCCACAGCCUCAGA |59 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CDC25A | ||||||||||||||||||||
Synonyms | CDC25A2 | ||||||||||||||||||||
Description | cell division cycle 25A | ||||||||||||||||||||
Transcript | NM_001789 | ||||||||||||||||||||
Other Transcripts | NM_201567 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CDC25A | |||||||||||||||||||||
3'UTR of CDC25A (miRNA target sites are highlighted) |
>CDC25A|NM_001789|3'UTR 1 GGGCGGCAGGACCAGCCAGCAGCAGCCCAAGCTTCCCTCCATCCCCCTTTACCCTCTTTGCTGCAGAGAAACTTAAGCAA 81 AGGGGACAGCTGTGTGACATTTGGAGAGGGGGCCTGGGACTTCCATGCCTTAAACCTACCTCCCACACTCCCAAGGTTGG 161 AGCCCAGGGCATCTTGCTGGCTACGCCTCTTCTGTCCCTGTTAGACGTCCTCCGTCCATATCAGAACTGTGCCACAATGC 241 AGTTCTGAGCACCGTGTCAAGCTGCTCTGAGCCACAGTGGGATGAACCAGCCGGGGCCTTATCGGGCTCCAGCCATCTCA 321 TGAGGGGAGAGGAGACGGAGGGGAGTAGAGAAGTTACACAGAAATGCTGCTGGCCAAATAGCAAAGACAACCTGGGAAGG 401 AAAGGTCTTTGTGGGATAATCCATATGTTTAATTTATTCAACTTCATCAATCACTTTATTTTATTTTTTTTTCTAACTCC 481 TGGAGACTTATTTTACTGCTTCATTAGGTTGAAATACTGCCATTCTAGGTAGGGTTTTATTATCCCAGGGACTACCTCGG 561 CTTTTAATTTAAAAAAAAAAAAGAAGTGGGTAAGAAAATGCAAACCTGTTATAAGTTATCGGACAGAAAGCTAGGTGCTC 641 TGTCACCCCCAGGAGGCGCTGTGGTACTGGGGCTGCTGCTATTTAAGCCAAGAACTGAGGTCCTGGTGAGAGCGTTGGAC 721 CCAGGCTTGGCTGCCTGACATAAGCTAAATCTCCCAGACCCACCACTGGCTACCGATATCTATTTGGTGGGAGGTGTGGC 801 CCTGTTCTTCCTCACCCCAGTTCCATGACATTGGCTGGTATAGGAGCCACAGTCAGGAAAGCACTTGAGGCAGCATCTGT 881 TGGGCCACCCCCGGCTCAGTGCTGGAATGTTGCAGTGTAGGTTTCCCAGGGAAGGGGGGTGGGGGTAGGTGGGCTCCACA 961 GGATGGGGGAGGAGCATGTCCACTGAGTATCTTCCTTATGTTGCTGTGATATTGATAGCTTTTATTTTCTAATTTTTAAA 1041 AAATGGTCATATTATGAGTCAAAGAGTATCAAATCAGTGTTGGATGGACCACCCAAGGGTGAGGAGAGGGGCTGGAAGCC 1121 CTGGGCATTAGGAGAAGGGAGTGGGTGCTGGCATGGACATGACTGGATAGAATTTTCTCAGGAGGGAGCTTGGTGGATTT 1201 TGAAGGTAAAACTTTCTGGGTTTATCATGTTTTAATTTTAGAGACAGGGAGTGATGAATCATCACCGGTTGTCCCCTTAT 1281 CTAACTCCATAAAAGTGGGAATTTCAAAAGAACACCTCATCCAAGGAGCTGGGGCAGACTTCATTGATTCTAGAGAGACC 1361 TGTTTCAGTGCCTACTCATCCCTGCCCTCTGGTGCCAGCCTCCTTACCATCACGGCTTCACTGAGGTGTAGGTGGGTTTT 1441 TCTTAAACAGGAGACAGTCTCTCCCCTCTTACCTCAACTTCTTGGGGTGGGAATCAGTGATACTGGAGATGGCTAGTTGC 1521 TGTGTTACGGGTTTGAGTTACATTTGGCTATAAAACAATCTTGTTGGGAAAAATGTGGGGGAGAGGACTTCTTCCTACAC 1601 GCGCATTGAGACAGATTCCAACTGGTTAATGATATTGTTTGTAAGAAAGAGATTCTGTTGGTTGACTGCCTAAAGAGAAA 1681 GGTGGGATGGCCTTCAGATTATACCAGCTTAGCTAGCATTACTAACCAACTGTTGGAAGCTCTGAAAATAAAAGATCTTG 1761 AACCCATAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000302506.3 | 3UTR | CGCUGUGGUACUGGGGCUGCUGCUAUUUAAGCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
64 hsa-miR-4323 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052834 | NOL11 | nucleolar protein 11 | 1 | 1 | ||||||||
MIRT082489 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT117166 | PER1 | period circadian clock 1 | 2 | 2 | ||||||||
MIRT157951 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT286013 | TVP23B | trans-golgi network vesicle protein 23 homolog B | 2 | 2 | ||||||||
MIRT310457 | REST | RE1 silencing transcription factor | 2 | 2 | ||||||||
MIRT338984 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT404223 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT451439 | TJP3 | tight junction protein 3 | 2 | 2 | ||||||||
MIRT463541 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT466981 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT479627 | CDC25A | cell division cycle 25A | 2 | 2 | ||||||||
MIRT487983 | SEC14L3 | SEC14 like lipid binding 3 | 2 | 4 | ||||||||
MIRT488661 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT489925 | RTKN | rhotekin | 2 | 2 | ||||||||
MIRT490209 | PKNOX2 | PBX/knotted 1 homeobox 2 | 2 | 2 | ||||||||
MIRT494896 | ZNF662 | zinc finger protein 662 | 2 | 2 | ||||||||
MIRT495380 | RELT | RELT, TNF receptor | 2 | 2 | ||||||||
MIRT495549 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT499104 | AGRN | agrin | 2 | 2 | ||||||||
MIRT500036 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 8 | ||||||||
MIRT501135 | SLC2A1 | solute carrier family 2 member 1 | 2 | 2 | ||||||||
MIRT505573 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT508164 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 8 | ||||||||
MIRT512383 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT512719 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT520904 | STMN1 | stathmin 1 | 2 | 2 | ||||||||
MIRT526361 | TIMMDC1 | translocase of inner mitochondrial membrane domain containing 1 | 2 | 2 | ||||||||
MIRT526847 | GALNT11 | polypeptide N-acetylgalactosaminyltransferase 11 | 2 | 2 | ||||||||
MIRT526945 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 4 | ||||||||
MIRT527028 | PABPN1L | poly(A) binding protein nuclear 1 like, cytoplasmic | 2 | 2 | ||||||||
MIRT527988 | TSLP | thymic stromal lymphopoietin | 2 | 2 | ||||||||
MIRT532202 | MPDU1 | mannose-P-dolichol utilization defect 1 | 2 | 2 | ||||||||
MIRT533691 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT535020 | PRMT7 | protein arginine methyltransferase 7 | 2 | 4 | ||||||||
MIRT535054 | PQLC1 | PQ loop repeat containing 1 | 2 | 2 | ||||||||
MIRT538987 | BCL2L2 | BCL2 like 2 | 2 | 2 | ||||||||
MIRT552232 | SART3 | squamous cell carcinoma antigen recognized by T-cells 3 | 2 | 2 | ||||||||
MIRT553259 | TVP23C | trans-golgi network vesicle protein 23 homolog C | 2 | 2 | ||||||||
MIRT555157 | PTPDC1 | protein tyrosine phosphatase domain containing 1 | 2 | 2 | ||||||||
MIRT565202 | TSC22D4 | TSC22 domain family member 4 | 2 | 2 | ||||||||
MIRT566199 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT566526 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT568464 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT572231 | ATG2A | autophagy related 2A | 2 | 2 | ||||||||
MIRT573096 | NDUFA7 | NADH:ubiquinone oxidoreductase subunit A7 | 2 | 2 | ||||||||
MIRT573326 | RFC5 | replication factor C subunit 5 | 2 | 2 | ||||||||
MIRT632802 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT646433 | ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 2 | 3 | ||||||||
MIRT647826 | MTG1 | mitochondrial ribosome associated GTPase 1 | 2 | 4 | ||||||||
MIRT652191 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT653800 | SIRPA | signal regulatory protein alpha | 2 | 2 | ||||||||
MIRT666949 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT684833 | SCAI | suppressor of cancer cell invasion | 2 | 2 | ||||||||
MIRT687294 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT700188 | RIMKLB | ribosomal modification protein rimK like family member B | 2 | 2 | ||||||||
MIRT701784 | MSL2 | MSL complex subunit 2 | 2 | 2 | ||||||||
MIRT705958 | ACY1 | aminoacylase 1 | 2 | 2 | ||||||||
MIRT705998 | ABHD14A-ACY1 | ABHD14A-ACY1 readthrough | 2 | 2 | ||||||||
MIRT717107 | PXDC1 | PX domain containing 1 | 2 | 2 | ||||||||
MIRT717586 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT722148 | SLC2A8 | solute carrier family 2 member 8 | 2 | 2 | ||||||||
MIRT723479 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT725221 | PEA15 | phosphoprotein enriched in astrocytes 15 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|